The advancement of siRNA-based nanomedicine for tumor therapy

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• Small interfering RNA (siRNA) utilizes RNA interference (RNAi) for gene expression down-regulation.
• siRNA therapeutics show high efficiency and specificity but face clinical hurdles.
• Challenges include siRNA instability, off-target effects, and immune responses.

Purpose of the Study:

• To review siRNA mechanisms and challenges in tumor therapy.
• To highlight nanomaterial carriers for siRNA delivery.
• To discuss siRNA-based nanomedicine applications in various cancer treatment modalities.

Main Methods:

• Exploration of siRNA mechanisms and RNAi.
• Review of nanomaterial-based siRNA delivery systems (lipid, polymeric, inorganic nanoparticles).
• Analysis of siRNA nanomedicine applications in chemotherapy, phototherapy, and immunotherapy.

Main Results:

• Nanomaterials effectively serve as carriers for siRNA delivery.
• siRNA nanomedicine strategies show promise in diverse cancer therapies.
• Recent clinical advancements in siRNA-based tumor treatment are presented.

Conclusions:

• Nanomaterial carriers are crucial for overcoming siRNA delivery challenges.
• siRNA nanomedicine holds significant potential for advanced cancer treatment.
• Further research and therapeutic development are warranted for clinical translation.